In addition, they showed that an inducible Albumin-MYC mouse model for liver cancer has 50% mortality by ~40 days post-induction; however, genetic ablations of both Lin28a and Lin28b in the liver resulted in ~70% of Albumin-MYC mice surviving to 150 days post-induction, the time at which the study terminated. The gene discussed is MYC; the disease is liver cancer.